Evaluating the Safety and Immune Response to a Live H7N9 Influenza Virus Vaccine Followed by an Inactivated H7N9 Influenza Virus Vaccine, Given at Varying Intervals

NCT02151344 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

100

Enrollment

NIH

Sponsor class

Conditions

Influenza A Virus, H7N9 Subtype

Interventions

BIOLOGICAL: H7N9 A/Anhui/13 ca influenza virus vaccine
BIOLOGICAL: Inactivated subvirion H7N9 vaccine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)